Triple
T18923912
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | WHO Collaborating Centre for Drug Statistics Methodology |
E462928
|
entity |
| Predicate | methodologyName |
P133810
|
FINISHED |
| Object | ATC/DDD methodology |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: ATC/DDD methodology | Statement: [WHO Collaborating Centre for Drug Statistics Methodology, methodologyName, ATC/DDD methodology]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: ATC/DDD methodology Context triple: [WHO Collaborating Centre for Drug Statistics Methodology, methodologyName, ATC/DDD methodology]
-
A.
WHO Collaborating Centre for Drug Statistics Methodology
The WHO Collaborating Centre for Drug Statistics Methodology is a specialized World Health Organization center responsible for developing and maintaining international standards for drug classification and consumption statistics, including the ATC/DDD system.
-
B.
Defined Daily Dose system
chosen
The Defined Daily Dose system is a standardized measure used in pharmacology to quantify and compare drug consumption by assigning an assumed average maintenance dose per day for a drug’s main indication in adults.
-
C.
Pharmacovigilance Risk Assessment Committee within the European Medicines Agency
The Pharmacovigilance Risk Assessment Committee within the European Medicines Agency is an expert body responsible for evaluating and monitoring the safety of medicines across the European Union and providing recommendations on managing and communicating medicine-related risks.
-
D.
FDA Risk Evaluation and Mitigation Strategies authority
The FDA Risk Evaluation and Mitigation Strategies authority is the U.S. Food and Drug Administration’s power to require special safety measures and monitoring programs for certain high-risk prescription drugs to ensure their benefits outweigh their risks.
-
E.
World Health Organization Model List of Essential Medicines
The World Health Organization Model List of Essential Medicines is a periodically updated catalog of the most effective, safe, and cost-efficient medicines deemed essential for meeting the priority health needs of populations worldwide.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: methodologyName Context triple: [WHO Collaborating Centre for Drug Statistics Methodology, methodologyName, ATC/DDD methodology]
-
A.
methodologyType
Indicates the specific kind or category of method or procedure used in carrying out an activity or study.
-
B.
methodologicallyAssociatedWith
Indicates a relationship where two entities are connected through shared, related, or jointly applied methods, procedures, or methodological approaches.
-
C.
methodologicalStyle
Indicates the characteristic approach, techniques, or procedures used in carrying out a method or research process.
-
D.
describesMethodology
Indicates that one entity explains, specifies, or characterizes the methodology or procedure used by another entity.
-
E.
methodologicalStatus
Indicates the methodological role or classification that one entity assigns to another within a research or analytical framework.
- F. None of above. chosen
Provenance (4 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d8dcfdbbb881909964fa5a75bd0b48 |
completed | April 10, 2026, 11:20 a.m. |
| NER | Named-entity recognition | batch_69e5c9b549448190850d7eed4de7872b |
completed | April 20, 2026, 6:37 a.m. |
| PD | Predicate disambiguation | batch_69e4a2e9e6488190ba8df92c8058ed88 |
completed | April 19, 2026, 9:39 a.m. |
| PDg | Predicate description generation | batch_69e4ad8e075c8190ad561edc5e520057 |
completed | April 19, 2026, 10:25 a.m. |
Created at: April 10, 2026, 11:59 a.m.